Phase I trial combining motexafin gadolinium with docetaxel in the treatment of advanced solid tumors.

被引：0
|
作者：
Phan, S
Messina, P
Buffan, M
Salemi, ML
Pandya, K
Wilmot, JP
机构：
[1] Pharmacycl Inc, Sunnyvale, CA USA
[2] Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3203
引用
收藏
页码：244S / 244S
页数：1
相关论文
共 50 条
  • [31] Phase I Clinical Trial of Pegylated Liposomal Doxorubicin and Docetaxel in Patients With Advanced Solid Tumors
    Iqbal, Syma
    Tsao-Wei, Denice D.
    Quinn, David I.
    Gitlitz, Barbara J.
    Groshen, Susan
    Aparicio, Ana
    Lenz, Heinz Josef
    El-Khoueiry, Anthony
    Pinski, Jacek
    Garcia, Agustin A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (01): : 27 - 31
  • [32] Phase I trial of docetaxel (DOTAX) and topotecan hydrochloride (TOPO) in patients with advanced solid tumors
    Tkaczuk, K
    Brooks, S
    Minford, J
    Meisenberg, B
    Fedenko, K
    Sivasailam, S
    Tait, N
    VanEcho, D
    ANNALS OF ONCOLOGY, 1998, 9 : 134 - 134
  • [33] Phase I dose escalation trial of biweekly pemetrexed in combination with docetaxel in advanced solid tumors
    Garland, L. L.
    Cranmer, L., III
    Gerstner, G.
    Walker, R.
    Obregon, Y.
    Ebbinghaus, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [34] Dual inhibition of VEGF pathway: Phase I trial of bevacizumab and cediranib in advanced solid tumors.
    Garrido-Laguna, I.
    Kurzrock, R.
    Wheler, J. J.
    Falchook, G. S.
    Piha-Paul, S. A.
    Fu, S.
    Naing, A.
    Hinojosa, C.
    Mistry, R.
    Scamardo, A.
    Culotta, K. S.
    Ekmekcioglu, S.
    Wen, S.
    Camacho, L. H.
    Ivy, S. P.
    Hong, D. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [35] Results of a phase I trial combining ridaforolimus (mTOR inhibitor) and MK-0752 (Notch inhibitor) in patients with advanced solid tumors.
    Piha-Paul, Sarina Anne
    Munster, Pamela N.
    Hollehecque, Antoine
    Argiles, Guillem
    Dajanl, Olav
    Cheng, Jonathan D.
    Wang, Ruixue
    Swift, Ann M.
    Tosolini, Alessandra
    Gupta, Shilpa
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] PX-866 and docetaxel in patients with advanced solid tumors.
    Jimeno, Antonio
    Senzer, Neil N.
    Rudin, Charles M.
    Ma, Wen Wee
    Halmos, Balazs
    Schnadig, Ian D.
    Levy, Benjamin
    Hausman, Diana Felice
    Peterson, Scott
    Walker, Luke N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [37] A phase I study of gemcitabine and docetaxel for advanced stage solid tumors
    Poole, ME
    Bernard, SA
    Churchel, MA
    Weissler, MC
    Calvo, B
    Cance, W
    Ollila, D
    Koruda, M
    Behrns, K
    Detterbeck, FC
    CANCER INVESTIGATION, 2003, 21 (03) : 350 - 354
  • [38] Phase I study of docetaxel and ifosfamide in patients with advanced solid tumors
    Pronk, L
    Shrijvers, D
    LocciTonelli, D
    Verweij, J
    VanOosterom, AT
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 961 - 961
  • [39] Phase I evaluation of docetaxel and topotecan for patients with advanced solid tumors
    Tsao, AS
    Shin, DM
    Palmer, JL
    Lee, JS
    Glisson, BS
    CANCER, 2004, 100 (10) : 2240 - 2245
  • [40] Phase I study on docetaxel and Gemcitabine in patients with advanced solid tumors
    Jaremtchuk, AV
    Zarba, JJ
    Ferro, A
    ANNALS OF ONCOLOGY, 1998, 9 : 138 - 139
12345